We are live on ! Find out more
RBOT

Vicarious Surgical
RBOT

Delisted

RBOT was delisted on the 2nd of March, 2026.

Back to rankings

30 hedge funds and large institutions have $13.4M invested in Vicarious Surgical in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 6

13% more capital invested

Capital invested by funds: $11.8M → $13.4M (+$1.55M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.35% less ownership

Funds ownership: 34.14% → 33.79% (-0.35%)

3% less funds holding

Funds holding: 31 → 30 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
30
Holders Change
-1
Holders Change %
-3.23%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
9
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$52.7K
2
DnB Asset Management
DnB Asset Management
Norway
+$22.9K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$8.9K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.58K
5
SS
SBI Securities
Japan
+$726

Top Sellers

Rank Fund Capital Flow
1
MAMHA
MY.Alpha Management HK Advisors
Hong Kong
-$117K
2
DP
DDD Partners
Washington
-$48.5K
3
Millennium Management
Millennium Management
New York
-$33.7K
4
UBS Group
UBS Group
Switzerland
-$16.9K
5
Renaissance Technologies
Renaissance Technologies
New York
-$10.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
VS
1
VK Services
California
$7.24M – – –
DP
2
DDD Partners
Washington
$1.55M -$48.5K -6,677 -3%
MAMHA
3
MY.Alpha Management HK Advisors
Hong Kong
$1.06M -$117K -16,056 -10%
Vanguard Group
4
Vanguard Group
Pennsylvania
$990K – – –
AMH
5
Aspex Management (HK)
Hong Kong
$650K – – –
CFM
6
Comprehensive Financial Management
California
$518K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$243K +$4.58K +631 +2%
BlackRock
8
BlackRock
New York
$219K +$52.7K +7,262 +33%
DnB Asset Management
9
DnB Asset Management
Norway
$219K +$22.9K +3,154 +12%
Millennium Management
10
Millennium Management
New York
$170K -$33.7K -4,643 -17%
MAM
11
Maytree Asset Management
Hong Kong
$134K – – –
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$123K +$8.9K +1,225 +8%
BCM
13
Bridgeway Capital Management
Texas
$88.5K – – –
Renaissance Technologies
14
Renaissance Technologies
New York
$83.5K -$10.9K -1,500 -12%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$38K +$109 +15 +0.3%
Morgan Stanley
16
Morgan Stanley
New York
$13.2K -$2.26K -311 -15%
Osaic Holdings
17
Osaic Holdings
Arizona
$12.3K – – –
AF
18
Allworth Financial
California
$7.75K +$240 +33 +3%
HFS
19
Hughes Financial Services
Virginia
$2.96K – – –
FFWM
20
Future Financial Wealth Management
Ohio
$1.57K – – –
AAP
21
Arax Advisory Partners
Colorado
$1.35K – – –
PNC Financial Services Group
22
PNC Financial Services Group
Pennsylvania
$1.25K – – –
UBS Group
23
UBS Group
Switzerland
$1.08K -$16.9K -2,330 -94%
SS
24
SBI Securities
Japan
$803 +$726 +100 +1,429%
JP Morgan Chase
25
JP Morgan Chase
New York
$661 +$51 +7 +9%
1
2

RBOT Hedge Fund Activity: Q2 2025 in Review

30 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q2 2025, worth a combined $13.4M — up 13% from $11.8M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of RBOT and 1 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 9 added.

The largest buyer was BlackRock, adding an estimated $52.7K. The largest seller was MY.Alpha Management HK Advisors, cutting an estimated $117K.

  • 30 institutional investors held Vicarious Surgical (RBOT) as of Q2 2025, down from 31 in Q1 2025.
  • Funds reported $13.4M of Vicarious Surgical stock for Q2 2025, up 13% quarter-over-quarter.
  • 1 fund opened new Vicarious Surgical positions in Q2 2025 and 2 closed out, a net change of -1 holder.
  • The largest Vicarious Surgical buyer in Q2 2025 was BlackRock, an estimated $52.7K added.
  • The largest Vicarious Surgical seller in Q2 2025 was MY.Alpha Management HK Advisors, an estimated $117K sold.

Based on aggregated 13F filings for Q2 2025.